The Multicenter Randomized HYpertension and VALUEs (HYVALUE) Trial

NACompletedINTERVENTIONAL
Enrollment

960

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Hypertension
Interventions
BEHAVIORAL

Intervention Values Affirmation

Participants are asked to circle the two or three values that are MOST important to them. Next, participants are asked to think about times when the values chosen might be important to THEMSELVES and then write a few sentences to describe when and why they might be important.

BEHAVIORAL

Control Values Affirmation

Participants are asked to circle the two or three items that are LEAST important to them. Next, participants are asked to think about times when the values chosen might be important to SOMEONE ELSE and then write a few sentences to describe when and why they might be important.

Trial Locations (3)

20852

Kaiser Permanente Mid Atlantic States, Rockville

80204

Denver Health and Hospital Authority, Denver

80205

Kaiser Permanente of Colorado, Denver

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University of Colorado, Boulder

OTHER

collaborator

Kaiser Permanente

OTHER

collaborator

Denver Health and Hospital Authority

OTHER

lead

University of Colorado, Denver

OTHER

NCT03028597 - The Multicenter Randomized HYpertension and VALUEs (HYVALUE) Trial | Biotech Hunter | Biotech Hunter